[1］张记,吴玉章,阎萍.SWI/SNF染色质重塑在肿瘤中的研究进展［J］.基础医学与临床,2016,36(10):1437-1440.
ZHANG J,WU YZ,YAN P.Research progress of SWI/SNF chromatin remodeling in malignancies［J］.Basic ＆ Clinical Medicine,2016,36(10):1437-1440.
[2］ALVER BH,KIM KH,LU P,et al.The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers［J］.Nat Commun,2017,8:14648.
[3］REISMAN D,GLAROS S,THOMPSON EA.The SWI/SNF complex and cancer［J］.Oncogene,2009,28(14):1653-1668.
[4］ROBERTS CWM,ORKIN SH.The SWI/SNF complex-chromatin and cancer［J］.Nat Rev Cancer,2004,4(2):133-142.
[5］夏秋媛,周晓军.SWI/SNF染色质重塑复合物与肾脏肿瘤［J］.临床与实验病理学杂志,2015,25(03):313-315.
XIA QY,ZHOU XJ.SWI/SNF chromatin remodeling complex and renal tumor［J］.Journal of Clinical and Experimental Pathology,2015,25(03):313-315.
[6］HARGREAVES DC,CRABTREE GR.ATP-dependent chromatin remodeling:genetics,genomics and mechanisms［J］.Cell Res,2011,21(3):396-420.
[7］KWON SJ,PARK JH,PARK EJ,et al.ATM-mediated phosphorylation of the chromatin remodeling enzyme BRG1 modulates DNA double-strand break repair［J］.Oncogene,2015,34(3):303-313.
[8］SHAIN AH,POLLACK JR.The spectrum of SWI/SNF mutations,ubiquitous in human cancers［J］.PLoS One,2013,8(1):e55119.
[9］WANG L,YU J,YU Z,et al.Structure of nucleosome-bound human PBAF complex［J］.Nat Commun,2022,13(1):7644.
[10］SCHICK S,GROSCHE S,KOHL KE,et al.Acute BAF perturbation causes immediate changes in chromatin accessibility［J］.Nat Genet,2021,53(3):269-278.
[11］GORDON MD,NUSSE R.Wnt signaling:multiple pathways,multiple receptors,and multiple transcription factors［J］.J Biol Chem,2006,281(32):22429-22433.
[12］STROBECK MW,KNUDSEN KE,FRIBOURG AF,et al.BRG-1 is required for RB-mediated cell cycle arrest［J］.Proc Natl Acad Sci USA,2000,97(14):7748-7753.
[13］MITTAL P,ROBERTS CWM.The SWI/SNF complex in cancer-biology,biomarkers and therapy［J］.Nat Rev Clin Oncol,2020,17(7):435-448.
[14］丁健,王飞,金景姬,等.表观遗传之染色质重塑［J］.生物化学与生物物理进展,2015,42(11):24-32.
DING J,WANG F,JIN JJ,et al.Chromatin remodeling in epigenetics［J］.Progress in Biochemistry and Biophysics,2015,42(11):24-32.
[15］TOLSTORUKOV MY,SANSAM CG,LU P,et al.SWI/SNF chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters［J］.Proc Natl Acad Sci USA,2013,110(25):10165-10170.
[16］WEISSMAN B,KNUDSEN KE.Hijacking the chromatin remodeling machinery:Impact of SWI/SNF perturbations in cancer［J］.Cancer Res,2009,69(21):8223-8230.
[17］MASHTALIR N,D'AVINO AR,MICHEL BC,et al.Modular organization and assembly of SWI/SNF family chromatin remodeling complexes［J］.Cell,2018,175(5):1272-1288.e20.
[18］LU P,ROBERTS CW.The SWI/SNF tumor suppressor complex:Regulation of promoter nucleosomes and beyond［J］.Nucleus,2013,4(5):374.
[19］BOSSEN C,MURRE CS,CHANG AN,et al.The chromatin remodeler Brg1 activates enhancer repertoires to establish B cell identity and modulate cell growth［J］.Nat Immunol,2015,16(7):775-784.
[20］ALEXANDER JM,HOTA SK,HE D,et al.Brg1 modulates enhancer activation in mesoderm lineage commitment［J］.Development,2015,142(8):1418-1430.
[21］CHATTERJEE SS,BISWAS M,BOILA LD,et al.SMARCB1 deficiency integrates epigenetic signals to oncogenic gene expression program maintenance in human acute myeloid leukemia［J］.Mol Cancer Res,2018,16(5):791-804.
[22］HODGES HC,STANTON BZ,CERMAKOVA K,et al.Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers［J］.Nat Struct Mol Biol,2018,25(1):61-72.
[23］WOLF BK,ZHAO Y,MCCRAY A,et al.Cooperation of chromatin remodeling SWI/SNF complex and pioneer factor AP-1 shapes 3D enhancer landscapes［J］.Nat Struct Mol Biol,2022,30(1):10-21.
[24］HU G,SCHONES DE,CUI K,et al.Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1［J］.Genome Res,2011,21(10):1650-1658.
[25］郭庆,饶秋,周志毅.肿瘤中SWI/SNF复合物亚基变异的作用及其相关治疗策略进展［J］.肿瘤防治研究,2019,046(007):644-649.
GUO Q,RAO Q,ZHOU ZY.Role of SWI/SNF complex subunit a5normality in tumors and progress of related therapeutic strategies［J］.Cancer Research on Prevention and Treatment,2019,046(007):644-649.
[26］BARISIC D,STADLER MB,IURLARO M,et al.Mammalian ISWI and SWI/SNF selectively mediate binding of distinct transcription factors［J］.Nature,2019,569(7754):136-140.
[27］LU C,ALLIS CD.SWI/SNF complex in cancer:'Remodeling' mechanisms uncovered［J］.Nat Genet,2017,49(2):178.
[28］NAGARAJAN S,RAO SV,SUTTON J,et al.ARID1A influences HDAC1/BRD4 activity,intrinsic proliferative capacity and breast cancer treatment response ［J］.Nat Genet,2020,52(2):187-197.
[29］WANG L,DENG CH,LUO Q,et al.Inhibition of Arid1a increases stem/progenitor cell-like properties of liver cancer［J］.Cancer Lett,2022,546:215869.
[30］DALEY GQ.Common themes of dedifferentiation in somatic cell reprogramming and cancer［J］.Cold Spring Harb Symp Quant Biol,2008,73:171-174.
[31］PARK MT,LEE SJ.Cell cycle and cancer［J］.J Biochem Mol Biol,2003,36(1):60-65
[32］STANTON BZ,HODGES C,CALARCO JP,et al.Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin［J］.Nat Genet,2016,49(2):282-288.
[33］BRACKEN AP,BRIEN GL,VERRIJZER CP.Dangerous liaisons:interplay between SWI/SNF,NuRD,and polycomb in chromatin regulation and cancer［J］.Genes Dev,2019,33(15-16):936-959.
[34］DROSOS Y,MYERS JA,XU B,et al.NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibition［J］.Mol Cell,2022,82(13):2472-2489.e8.
[35］GALL TROSELJ K,NOVAK KUJUNDZIC R,UGARKOVIC D.Polycomb repressive complex's evolutionary conserved function:the role of EZH2 status and cellular background［J］.Clin Epigenetics,2016,8(1):55.
[36］RAJABI H,HIRAKI M,KUFE D.MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells［J］.Oncogene,2018,37(16):2079-2088.
[37］MARTIN N,RAGUZ S,DHARMALINGAM G,et al.Co-regulation of senescence-associated genes by oncogenic homeobox proteins and polycomb repressive complexes［J］.Cell Cycle,2013,12(14):2194-2199.
[38］LAUGESEN A,HOJFELDT JW,HELIN K.Role of the polycomb repressive complex 2(PRC2) in transcriptional regulation and cancer［J］.Cold Spring Harb Perspect Med,2016,6(9):a026575.
[39］GAO Z,ZHANG J,BONASIO R,et al.PCGF homologs,CBX proteins,and RYBP define functionally distinct PRC1 family complexes［J］.Mol Cell,2012,45(3):344-356.
[40］WILSON BG,WANG X,SHEN X,et al.Epigenetic antgonism between polycomb and SWI/SNF complexes during oncogenic transformation［J］.Cancer Cell,2010,18(4):316-328.
[41］SCOTT TL,RANGASWAMY S,WICKER CA,et al.Repair of oxidative DNA damage and cancer:Recent progress in DNA base excision repair［J］.Antioxid Redox Signal,2014,20(4):708-726.
[42］REDDY JP,PEDDIBHOTLA S,BU W,et al.Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation［J］.Proc Natl Acad Sci USA,2010,107(8):3728-3733.
[43］HEINEN CD,SCHMUTTE C,FISHEL R.DNA repair and tumorigenesis:Lessons from hereditary cancer syndromes［J］.Cancer Biol Ther,2002,1(5):477-485.
[44］RIBEIRO-SILVA C,VERMEULEN W,LANS H.SWI/SNF:Complex complexes in genome stability and cancer［J］.DNA Repair(Amst),2019,77:87-95.
[45］NARGUND AM,XU C,MANDOLI A,et al.Chromatin rewiring by mismatch repair protein MSH2 alters cell adhesion pathways and sensitivity to BET inhibition in gastric cancer［J］.Cancer Res,2022,82(14):2538-2551.
[46］RAY A,MIR SN,WANI G,et al.Human SNF5/INI1,a component of the human SWI/SNF chromatin remodeling complex,promotes nucleotide excision repair by influencing ATM recruitment and downstream H2AX phosphorylation［J］.Mol Cell Biol,2009,29(23):6206-6219.
[47］SHEN J,PENG Y,WEI L,et al.ARID1A deficiency impairs the DNA damage checkpoint and sensitizes cells to PARP inhibitors［J］.Cancer Discov,2015,5(7):752-767.
[48］NAIDU SR,LOVE IM,IMBALZANO AN,et al.The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells［J］.Oncogene,2009,28(27):2492-2501.
[49］AHN J,KO M,LEE C,et al.Srg3,a mouse homolog of BAF155,is a novel p53 target and acts as a tumor suppressor by modulating p21WAF1/CIP1 expression［J］.Oncogene,2010,30(4):445.
[50］BOCHAR DA,WANG L,BENIYA H,et al.BRCA1 is associated with a human SWI/SNF-related complex:Linking chromatin remodeling to breast cancer［J］.Cell,2000,102(2):257-265.
[51］AGAIMY A,AMIN MB,GILL AJ,et al.SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma:Immunohistochemical analysis of 32 tumors from 28 patients［J］.Hum Pathol,2018,77:139-146.
[52］AGAIMY A,CHENG L,EGEVAD L,et al.Rhabdoid and undifferentiated phenotype in renal cell carcinoma:Analysis of 32 cases indicating a distinctive common pathway of dedifferentiation frequently associated with SWI/SNF complex deficiency［J］.Am J Surg Pathol,2017,41(2):253-262.
[53］AGAIMY A,BERTZ S,CHENG L,et al.Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tract［J］.Virchows Arch,2016,469(3):321-330.
[54］KOHASHI K,YAMAMOTO H,YAMADA Y,et al.SWI/SNF chromatin-remodeling complex status in SMARCB1/INI1-preserved epithelioid sarcoma［J］.Am J Surg Pathol,2018,42(3):312-318.
[55］IWAGAMI Y,EGUCHI H,NAGANO H,et al.miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1［J］.Br J Cancer,2013,109(2):502-511.
[56］CHANG B,SHENG W,WANG L,et al.SWI/SNF complex-deficient undifferentiated carcinoma of the gastrointestinal tract:clinicopathologic study of 30 cases with an emphasis on variable morphology,immune features,and the prognostic significance of different SMARCA4 and SMARCA2 subunit deficiencies［J］.Am J Surg Pathol,2022,46(7):889-906.
[57］KORENTZELOS D,ELISHAEV E,ZHAO C,et al.ARID1A,BRG1,and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma:a clinicopathologic,immunohistochemical,and next-generation sequencing analysis of a case series from a single institution［J］.Hum Pathol,2022,130:65-78.
[58］PATRICK L,THOMAS S,DANA K,et al.Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells［J］.Elife,2015,4:e06857.
[59］SALADI SV,KEENEN B,MARATHE HG,et al.Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness［J］.Mol Cancer,2010,9(1):280.
[60］WATANABE T,SEMBA S,YOKOZAKI H.Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells［J］.Br J Cancer,2010,104(1):146-154.
[61］WANG X,LEE RS,ALVER BH,et al.SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation［J］.Nat Genet,2017,49(2):289-295.
[62］KELSO TWR,PORTER DK,AMARAL ML,et al.Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers［J］.Elife,2017,6:e30506.
[63］HELMING KC,WANG X,WILSON BG,et al.ARID1B is a specific vulnerability in ARID1A-mutant cancers［J］.Nat Med,2014,20(3):251-254.
[64］WANG L,ZHAO Z,MEYER M,et al.CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis［J］.Cancer Cell,2014,25(1):21-36.
[65］ORLANDO KA,NGUYEN V,RAAB JR,et al.Remodeling the cancer epigenome:mutations in the SWI/SNF complex offer new therapeutic opportunities［J］.Expert Rev Anticancer Ther,2019,19(5):375-391.
[66］WILLIAMSON CT,MILLER R,PEMBERTON HN,et al.ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A［J］.Nat Commun,2016,7:13837.
[67］YANG H,CUI W,WANG L.Epigenetic synthetic lethality approaches in cancer therapy［J］.Clin Epigenetics,2019,11(1):136.
[68］WANG X,SANSAM CG,THOM CS,et al.Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1,the ATPase of the SWI/SNF chromatin remodeling complex［J］.Cancer Res,2009,69(20):8094-8101.
[69］LI N,LIU Q,HAN Y,et al.ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression［J］.Nat Commun,2022,13(1):7281.
[70］ZHU Y,YAN C,WANG X,et al.Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy［J］.Cancer Biol Ther,2022,23(1):104-111.
[71］ALAIWI SA,NASSAR AH,XIE W,et al.Mammalian SWI/SNF complex genomic alterations and immune checkpoint blockade in solid tumors［J］.Cancer Immunol Res,2020,8(8):1075-1084.